PT Charlie Hospital Semarang Tbk (IDX:RSCH)
366.00
-8.00 (-2.14%)
Last updated: Feb 6, 2026, 10:33 AM WIB
IDX:RSCH Revenue
PT Charlie Hospital Semarang Tbk had revenue of 18.92B IDR in the quarter ending September 30, 2025, with 61.96% growth. This brings the company's revenue in the last twelve months to 58.84B, up 23.25% year-over-year. In the year 2024, PT Charlie Hospital Semarang Tbk had annual revenue of 48.50B with 15.04% growth.
Revenue (ttm)
58.84B
Revenue Growth
+23.25%
P/S Ratio
16.85
Revenue / Employee
277.53M
Employees
212
Market Cap
991.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 48.50B | 6.34B | 15.04% |
| Dec 31, 2023 | 42.16B | 9.13B | 27.63% |
| Dec 31, 2022 | 33.03B | -2.52B | -7.10% |
| Dec 31, 2021 | 35.56B | 22.29B | 168.08% |
| Dec 31, 2020 | 13.26B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Lippo Karawaci Tbk | 8.56T |
| PT Medikaloka Hermina Tbk | 6.98T |
| PT Mitra Keluarga Karyasehat Tbk | 5.24T |
| PT Famon Awal Bros Sedaya Tbk | 2.30T |
| PT Sarana Meditama Metropolitan Tbk | 1.79T |
| PT Bundamedik Tbk | 1.55T |
| PT Murni Sadar Tbk | 1.26T |
| PT Kedoya Adyaraya Tbk | 448.65B |